Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.

Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, Dumont MD, Lenoir G, de Montalembert M.

Eur J Haematol. 2010 Mar;84(3):259-65. doi: 10.1111/j.1600-0609.2009.01379.x. Epub 2009 Nov 12.

PMID:
19912310
2.

Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Wang WC.

Cochrane Database Syst Rev. 2017 Jan 17;1:CD003146. doi: 10.1002/14651858.CD003146.pub3. Review.

PMID:
28094851
3.

Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.

Griessenauer CJ, Lebensburger JD, Chua MH, Fisher WS 3rd, Hilliard L, Bemrich-Stolz CJ, Howard TH, Johnston JM.

J Neurosurg Pediatr. 2015 Jul;16(1):64-73. doi: 10.3171/2014.12.PEDS14522. Epub 2015 Apr 3.

PMID:
25837886
4.

The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.

Cherry MG, Greenhalgh J, Osipenko L, Venkatachalam M, Boland A, Dundar Y, Marsh K, Dickson R, Rees DC.

Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430. Review.

5.

Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Wang WC, Dwan K.

Cochrane Database Syst Rev. 2013 Nov 14;(11):CD003146. doi: 10.1002/14651858.CD003146.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Jan 17;1:CD003146.

6.

Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.

Sheehan VA, Hansbury EN, Smeltzer MP, Fortner G, McCarville MB, Aygun B.

Pediatr Blood Cancer. 2013 Sep;60(9):1499-502. doi: 10.1002/pbc.24569. Epub 2013 Apr 26.

PMID:
23625812
7.

Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.

Bishop S, Matheus MG, Abboud MR, Cane ID, Adams RJ, Jackson SM, Kalpatthi R.

Blood Cells Mol Dis. 2011 Aug 15;47(2):125-8. doi: 10.1016/j.bcmd.2011.06.002. Epub 2011 Jul 2.

PMID:
21724428
8.

Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease.

Kwiatkowski JL, Yim E, Miller S, Adams RJ; STOP 2 Study Investigators.

Pediatr Blood Cancer. 2011 May;56(5):777-82. doi: 10.1002/pbc.22951. Epub 2010 Dec 23.

9.

Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities.

Aygun B, Wruck LM, Schultz WH, Mueller BU, Brown C, Luchtman-Jones L, Jackson S, Iyer R, Rogers ZR, Sarnaik S, Thompson AA, Gauger C, Helms RW, Ware RE; TCD With Transfusions Changing to Hydroxyurea (TWiTCH) Trial Investigators.

Am J Hematol. 2012 Apr;87(4):428-30. doi: 10.1002/ajh.23105. Epub 2012 Jan 9. No abstract available.

10.

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D.

N Engl J Med. 1998 Jul 2;339(1):5-11.

11.

Implementation of transcranial Doppler ultrasonography screening and primary stroke prevention in urban and rural sickle cell disease populations.

Hussain S, Nichols F, Bowman L, Xu H, Neunert C.

Pediatr Blood Cancer. 2015 Feb;62(2):219-223. doi: 10.1002/pbc.25306. Epub 2014 Nov 8.

PMID:
25381872
12.

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, Luchtman-Jones L, Rogers ZR, Hilliard L, Gauger C, Piccone C, Lee MT, Kwiatkowski JL, Jackson S, Miller ST, Roberts C, Heeney MM, Kalfa TA, Nelson S, Imran H, Nottage K, Alvarez O, Rhodes M, Thompson AA, Rothman JA, Helton KJ, Roberts D, Coleman J, Bonner MJ, Kutlar A, Patel N, Wood J, Piller L, Wei P, Luden J, Mortier NA, Stuber SE, Luban NL, Cohen AR, Pressel S, Adams RJ.

Lancet. 2016 Feb 13;387(10019):661-70. doi: 10.1016/S0140-6736(15)01041-7. Epub 2015 Dec 6.

13.

The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease.

Buchanan ID, James-Herry A, Osunkwo I.

J Pediatr Hematol Oncol. 2013 Oct;35(7):543-6. doi: 10.1097/MPH.0b013e318279caae.

PMID:
23211694
14.

Stroke prevention trial in sickle cell anemia.

Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, Roach S, Abboud M, Berman B, Driscoll C, Files B, Hsu L, Hurlet A, Miller S, Olivieri N, Pegelow C, Scher C, Vichinsky E, Wang W, Woods G, Kutlar A, Wright E, Hagner S, Tighe F, Waclawiw MA, et al.

Control Clin Trials. 1998 Feb;19(1):110-29.

PMID:
9492971
15.

Big strokes in small persons.

Adams RJ.

Arch Neurol. 2007 Nov;64(11):1567-74. Review.

PMID:
17998439
16.

Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.

Lee MT, Piomelli S, Granger S, Miller ST, Harkness S, Brambilla DJ, Adams RJ; STOP Study Investigators.

Blood. 2006 Aug 1;108(3):847-52.

17.

Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.

Alvarez O, Yovetich NA, Scott JP, Owen W, Miller ST, Schultz W, Lockhart A, Aygun B, Flanagan J, Bonner M, Mueller BU, Ware RE; Investigators of the Stroke With Transfusions Changing to Hydroxyurea Clinical Trial (SWiTCH).

Am J Hematol. 2013 Nov;88(11):932-8. doi: 10.1002/ajh.23547. Epub 2013 Aug 30.

18.

Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.

Miller ST, Wright E, Abboud M, Berman B, Files B, Scher CD, Styles L, Adams RJ; STOP Investigators.

J Pediatr. 2001 Dec;139(6):785-9.

PMID:
11743502
19.

Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.

Adams RJ, Brambilla D; Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators.

N Engl J Med. 2005 Dec 29;353(26):2769-78.

20.

Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.

Helton KJ, Adams RJ, Kesler KL, Lockhart A, Aygun B, Driscoll C, Heeney MM, Jackson SM, Krishnamurti L, Miller ST, Sarnaik SA, Schultz WH, Ware RE; SWiTCH Investigators.

Blood. 2014 Aug 7;124(6):891-8. doi: 10.1182/blood-2013-12-545186. Epub 2014 Jun 9.

Supplemental Content

Support Center